Association of cytokine gene polymorphisms and the release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone

International Immunopharmacology

Volumn 6, Issue 3, 2006, Pages 351-357

  Pawlik, A ^a   Baskiewicz Masiuk, M ^a   Machalinski, B ^a   Gawronska Szklarz, B ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Cytokine; Dexamethasone; Gene polymorphism; Methotrexate

Indexed keywords

CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; METHOTREXATE; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA POLYMORPHISM; DRUG EFFECT; FLOW CYTOMETRY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS; CYTOKINES; DEXAMETHASONE; GENOTYPE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES, MONONUCLEAR; METHOTREXATE; POLYMORPHISM, GENETIC;

EID: 31044452490     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2005.08.019     Document Type: Article

References (27)

1. S.C. Hoffmann, E.M. Stanley, E. Darrin Cox, N. Craighead, B.S. DiMercurio, and D.E. Koziol Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes Transplantation 72 2001 1444 1450
2. R.P. Donn, J.H. Barrett, A. Farhan, A. Stopford, L. Pepper, and E. Shelley Cytokine gene polymorphisms and susceptibility to juvenile idiopathic arthritis. British Pediatric Rheumatology Study Group Arthritis Rheum 44 2001 180 802
3. A. Cantagrel, F. Navaux, P. Loubet-Lescoulie, F. Nourhashemi, G. Enault, and M. Abbal Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis Arthritis Rheum 42 1999 1093 1100
4. E. Noguchi, M. Shibasaki, T. Arinami, K. Takeda, Y. Yokouchi, and T. Kawashima Association of asthma and the interleukin-4 promoter gene in Japanese Clin Exp Allergy 28 1998 449 453
5. E.S. Chan, and B.N. Cronstein Molecular action of methotrexate in inflammatory diseases Arthritis Res 4 2002 266 273
6. N. Auphan, J.A. Didonato, A. Helmberg, C. Rosette, and M. Karin Immunoregulatory genes and immunosuppression by glucocorticoids Arch Toxicol Suppl 19 1997 87 95
7. C.J. Edwards-Smith, J.R. Jonsson, D.M. Purdie, A. Bansal, C. Shorthouse, and E.E. Powell Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa Hepatology 30 1999 526 530
8. C. Perrey, V. Pravica, P.J. Sinnott, and I.V. Hutchinson Genotyping for polymorphism in interferon-gamma, interleukin-10, transforming growth factor-beta1 and tumor necrosis factor-alpha genes: a technical report Transpl Immunol 6 1998 193 197
9. M.P. Reynard, D. Turner, and C.V. Navarette Allele frequencies of polymorphisms of the tumour necrosis factor-alpha, interleukin-10, interferon-gamma and interleukin-2 genes in a North European Caucasoid group from the UK Eur J Immunogenet 27 2000 241 249
10. Z. Song, V. Casolaro, R. Chen, S.N. Georas, D. Monos, and S.J. Ono Plymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene J Immunol 156 1996 1131 1136
11. E. Louis, D. Franchimont, A. Piron, Y. Gevaert, N. Schaaf-Lafontaine, and S. Roland Tumor necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans Clin Exp Immunol 113 1998 401 406
12. A.G. Wilson, J.A. Symsons, T.L. McDowell, H.O. McDevitt, and G.W. Duff Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation Proc Natl Acad Sci U S A 93 1997 3195 3199
13. J. Saklatvala Glucocorticoids: do we know how they work? Arthritis Res 4 2002 146 150
14. A. Ray, and K.E. Prefontaine Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor Proc Natl Acad Sci U S A 91 1994 752 756
15. R.I. Scheiman, A. Guaberto, C.M. Jewell, J.A. Cidlowski, and A.S. Baldwin Jr. NF-kappa B by activated glucocorticoid receptors Mol Cell Biol 15 1995 943 953
16. K. Ito, P.J. Barnes, and I.M. Adcock Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1 beta-induced histone H4 acetylation on lysines 8 and 12 Mol Cell Biol 20 2000 6891 6903
17. C. Becker, K. Barbulescu, K. Hildner, K.H. Meyer zum Buschenfelde, and M.F. Neurath Activation and methotrexate-mediated suppression of the TNF alpha promoter in T cells and macrophages Ann N Y Acad Sci 859 1998 219 222
18. M.F. Neurath, K. Hildner, C. Becker, J.F. Schlaak, K. Barbulescu, and T. Germann Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppression Clin Exp Immunol 115 1999 42 55
19. K. Hildner, S. Finotto, C. Becker, J. Schlaak, P. Schirmacher, and P.R. Galle Tumour necrosis factor (TNF) production by T cell receptor-primed T lymphocytes is a target for low dose methotrexate in rheumatoid arthritis Clin Exp Immunol 118 1999 137 146
20. A. Spadaro, E. Taccari, V. Riccieri, F. Sensi, A. Sili Scavalli, and A. Zoppini Relationship of soluble interleukin-2-receptor and interleukin-6 with class-specific rheumatoid factors during low-dose methotrexate treatment in rheumatoid arthritis Rev Rhum Engl Ed 64 1997 89 94
21. A. Constantin, P. Loubet-Lescoulie, N. Lambert, B. Yassine-Diab, M. Abbal, and B. Mazieres Anti-inflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain reaction Arthritis Rheum 41 1998 48 57
22. L. Genestier, R. Paillot, S. Fournel, C. Ferraro, P. Miossec, and J.P. Revillard Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells J Clin Invest 102 1998 322 328
23. B.N. Cronstein, D. Naime, and E. Ostad The anti-inflammatory effects of methotrexate are mediated by adenosine Adv Exp Med Biol 370 1994 411 416
24. B.N. Cronstein, D. Naime, and E. Ostad The anti-inflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation J Clin Invest 92 1993 2675 2682
25. M.G. Bouma, R.K. Stad, F.A. van den Wildenberg, and WA. Buurman Differential regulatory effects of adenosine on cytokine release by activated human monocytes J Immunol 153 1994 4159 4168
26. F.G. Sajjadi, K. Takabayashi, A.C. Foster, R.C. Domingo, and G.S. Firestein Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors J Immunol 156 1996 3435 3442
27. O. Le Moine, P. Stordeur, L. Schandene, A. Marchant, D. de Groote, and M. Goldman Adenosine enhances IL-10 secretion by human monocytes J Immunol 156 1996 4408 4414